greeksoup/ stock research

Labcorp Holdings (LH) FY2023 results: revenue $12.2 billion, up 2.5% on the year

Labcorp Holdings Inc. (LH) reported revenue of $12.2 billion for fiscal 2023, the year ended 31 December 2023, up 2.5% on the year before. Net income was $418 million, down 67.3%, and diluted earnings per share $4.77. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2024.

Revenue
$12.2 billion
+2.5% on the year
FY2016FY2023
Operating margin
6.0%
12.1% a year earlier
FY2016FY2023
Net income
$418 million
-67.3% on the year
FY2016FY2023
Diluted EPS
$4.77
-65.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue12,16211,86413,136+2.5%
Cost of revenue8,7978,1558,144+7.9%
Gross profit3,3653,7094,992-9.3%
Gross margin27.7%31.3%38.0%
Selling, general and administrative2,0211,7631,690+14.7%
Operating income7261,4363,049-49.5%
Operating margin6.0%12.1%23.2%
Interest expense200180212+11.0%
Income tax188234690-19.4%
Net income4181,2792,377-67.3%
Net margin3.4%10.8%18.1%
Diluted EPS$4.77$13.97$24.39-65.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow1,3281,9563,110-32.1%
Capital expenditure454429422+5.7%
Free cash flow8741,5272,688-42.7%
Free cash flow margin7.2%12.9%20.5%
Cash from investing-1,172-1,652-885
Cash from financing-59.3-1,322-2,066
Depreciation and amortisation577537577+7.5%
Share-based compensation129117133+10.2%
Buybacks1,0001,1001,668-9.1%
Dividends paid2541950.0+30.1%
Dividend per share$2.88$2.16n/a+33.3%
Diluted shares, weighted88m92m98m-4.4%
Shares outstanding at period end84m88m98m-4.9%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity7,87510,09710,273-22.0%
Debt5,0545,3405,416-5.3%
Operating lease liabilities649653642-0.6%
Finance lease liabilities78.683.684.6-6.0%
Other liabilities3,0683,9823,968-22.9%
Total liabilities and equity16,72520,15520,385-17.0%
Fixed assets2,9122,7942,815+4.2%
Goodwill6,1426,1245,891+0.3%
Intangible assets3,3423,1243,736+7.0%
Cash and equivalents5373211,473+67.4%
Receivables1,9131,7862,262+7.2%
Inventory475471401+0.8%
Other assets1,4045,5373,808-74.6%
Total assets16,72520,15520,385-17.0%

10-K for the year ended 31 December 2023, filed 26 February 2024: the filing.